Sichuan, China

Long Li

This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Long Li - Innovator in Pharmaceutical Research

Introduction

Long Li is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for treating neurological disorders. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

One of Long Li's notable patents is titled "Salt of benzothiazole compound, and crystal form and use thereof." This invention provides a salt of a benzothiazole compound, specifically selected from pamoate and palmitate. The patent outlines the use of this compound in the preparation of drugs aimed at treating Parkinson's disease and restless leg syndrome. This innovative approach highlights the potential for new therapeutic options in the pharmaceutical market.

Career Highlights

Long Li is affiliated with the Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. His work at this esteemed institution has allowed him to collaborate with other talented researchers in the field. His dedication to advancing pharmaceutical science is evident in his research and patent contributions.

Collaborations

Throughout his career, Long Li has worked alongside notable colleagues such as Shidong Yi and Tianming Wang. These collaborations have fostered a productive research environment, leading to advancements in drug development and innovative solutions for complex health challenges.

Conclusion

Long Li's contributions to pharmaceutical research, particularly through his patent on benzothiazole compounds, demonstrate his commitment to improving healthcare outcomes. His work continues to inspire innovation in the field, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…